Skip to content
healthcare.dev
Get a free key

INVOKANA

NDC 50090-4364, canagliflozin, tablet, film coated, from A-S Medication Solutions.

Product NDC
50090-4364
Status
Listed
Labeler
A-S Medication Solutions
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204042
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50090-4364 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CANAGLIFLOZIN300 mg/1

Pharmacologic classes

P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
50090-4364-05009043640090 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9679460c-55f7-4826-b55c-fe116f020358

Use it

Look up 50090-4364 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50090-4364 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50090-4364. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.